Abstract: The invention relates to a process for treating lameness with an osseous, articular or osteoarticular component, comprising the administration, to a human or to an animal not suffering from arthritis or from fractures, of an effective amount of a bisphosphonic acid derivative of formula: 1
Type:
Application
Filed:
September 5, 2002
Publication date:
February 13, 2003
Applicant:
Sanofi Sante Nutrition Animale
Inventors:
Philippe Du Mesnil, Thierry Bardon, Dominique Thibaud
Abstract: The present invention relates to an anaesthetic veterinary pharmaceutical composition, comprising a general anaesthetic selected from phencyclidine derivatives such as ketamine or tiletamine, as well as 0.015 to 1.25 molar equivalents of selegiline, combined in a single pharmaceutical composition or presented separately.
Abstract: The invention relates to the use of selegiline for preparing pharmaceutical compositions useful for treating behavioral disorders with change of mood in dogs and cats.